Status:
COMPLETED
Long-Term Respiratory Muscle Strength in Young COVID-19 Patients
Lead Sponsor:
Karabuk University
Conditions:
COVID-19
Eligibility:
All Genders
18-25 years
Brief Summary
The coronavirus disease 2019 (COVID-19) is a highly contagious disorder caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a multisystem disease and therefore pres...
Eligibility Criteria
Inclusion
- Patients:
- diagnosed with COVID-19, with a positive polymerase chain reaction (PCR) test
- at least six months ago (long term)
- non-hospitalization due to COVID-19
- non-smoker / for ex-smokers with 10 pack x years or less of smoking
- not continuing any regular physical activity program
- Controls:
- non-smoker / for ex-smokers with 10 pack x years or less of smoking,
- not continuing any regular physical activity program
- willing to participate to the study
Exclusion
- receiving inpatient or intensive care treatment due to COVID-19
- having acute infection
- previous pulmonary resection or cardiac surgery
- having lung or heart comorbidities such as asthma
- chronic obstructive pulmonary disease (COPD) and heart failure
- uncontrolled hypertension
- history of malignancy
- neurological disease (e.g., Alzheimer, Multiple Sclerosis, Parkinson)
- rheumatologic diseases
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 21 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05381714
Start Date
January 1 2022
End Date
April 21 2023
Last Update
April 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karabuk University
Karabük, Turkey (Türkiye)